96 related articles for article (PubMed ID: 14582845)
1. Mechanistic effect of NMSO3 on replication of human immunodeficiency virus.
Nakamura M; Terada M; Kamada M; Yokono A; Nakamori S; Ohno T
Antivir Chem Chemother; 2003 Jul; 14(4):171-6. PubMed ID: 14582845
[TBL] [Abstract][Full Text] [Related]
2. Polysulfated sialic acid derivatives as anti-human immunodeficiency virus.
Terada M; Fujita S; Suda I; Mastico R
Biomed Pharmacother; 2005 Sep; 59(8):423-9. PubMed ID: 16143490
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of NMSO3 against adenovirus in vitro.
Kaneko H; Kato K; Mori S; Shigeta S
Antiviral Res; 2001 Dec; 52(3):281-8. PubMed ID: 11675145
[TBL] [Abstract][Full Text] [Related]
4. Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4.
Yang QE; Stephen AG; Adelsberger JW; Roberts PE; Zhu W; Currens MJ; Feng Y; Crise BJ; Gorelick RJ; Rein AR; Fisher RJ; Shoemaker RH; Sei S
J Virol; 2005 May; 79(10):6122-33. PubMed ID: 15857997
[TBL] [Abstract][Full Text] [Related]
5. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of inhibitory effect of NCC164 on replication of human immunodeficiency virus.
Nakamura M; Terada M; Matsuzaki K; Yoshida K; Ohno T
Microbiol Immunol; 2001; 45(3):217-23. PubMed ID: 11345531
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human immunodeficiency virus replication by RD6-Y664, a novel benzylhydroxylamine derivative.
Okamoto M; Fujiwara M; Kodama E; Yamamoto O; Shigeta S; Mitsuya H; Konno K; Yokota T; Baba M
Antivir Chem Chemother; 1999 Mar; 10(2):71-7. PubMed ID: 10335401
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by NMSO3 in tissue culture assays.
Wyde PR; Moylett EH; Chetty SN; Jewell A; Bowlin TL; Piedra PA
Antiviral Res; 2004 Jul; 63(1):51-9. PubMed ID: 15196820
[TBL] [Abstract][Full Text] [Related]
9. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures.
Szabó J; Cervenák L; Tóth FD; Prohászka Z; Horváth L; Kerekes K; Beck Z; Bácsi A; Erdei A; Peerschke EI; Füst G; Ghebrehiwet B
Clin Immunol; 2001 May; 99(2):222-31. PubMed ID: 11318594
[TBL] [Abstract][Full Text] [Related]
10. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.
Neffe AT; Meyer B
Angew Chem Int Ed Engl; 2004 May; 43(22):2937-40. PubMed ID: 15170309
[No Abstract] [Full Text] [Related]
11. Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine.
Chiang G; Sassaroli M; Louie M; Chen H; Stecher VJ; Sperber K
Clin Ther; 1996; 18(6):1080-92. PubMed ID: 9001825
[TBL] [Abstract][Full Text] [Related]
12. Anti-HIV-1 activity and structure-activity-relationship study of a fucosylated glycosaminoglycan from an echinoderm by targeting the conserved CD4 induced epitope.
Lian W; Wu M; Huang N; Gao N; Xiao C; Li Z; Zhang Z; Zheng Y; Peng W; Zhao J
Biochim Biophys Acta; 2013 Oct; 1830(10):4681-91. PubMed ID: 23769857
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic effects of kijimicin on inhibition of human immunodeficiency virus replication.
Yamauchi T; Nakamura M; Honma H; Ikeda M; Kawashima K; Ohno T
Mol Cell Biochem; 1993 Feb; 119(1-2):35-41. PubMed ID: 8455584
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo.
Kimura K; Mori S; Tomita K; Ohno K; Takahashi K; Shigeta S; Terada M
Antiviral Res; 2000 Jul; 47(1):41-51. PubMed ID: 10930645
[TBL] [Abstract][Full Text] [Related]
15. RD6-2198, a novel betain-type fluoroalkylated oligomer, inhibits the replications of human immunodeficiency virus type 1 and other enveloped viruses.
Fujiwara M; Ashida N; Okamoto M; Mizuta T; Ide T; Hanasaki Y; Katsuura K; Sawada H; Shigeta S; Konno K; Yokota T; Baba M
Antiviral Res; 1998 May; 38(2):141-9. PubMed ID: 9707376
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor.
Curreli F; Haque K; Xie L; Qiu Q; Xu J; Yong W; Tong X; Debnath AK
Bioorg Med Chem; 2015 Dec; 23(24):7618-28. PubMed ID: 26602829
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1 entry into murine cell lines and lymphocytes from transgenic mice expressing a glycoprotein 120-binding mutant mouse CD4.
Wieder KJ; Chatis P; Boltax J; Wieder I; Nuovo G; Strom TB
AIDS Res Hum Retroviruses; 1996 Jul; 12(10):867-76. PubMed ID: 8798971
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of NMSO3-resistant mutants of respiratory syncytial virus.
Kimura K; Ishioka K; Hashimoto K; Mori S; Suzutani T; Bowlin TL; Shigeta S
Antiviral Res; 2004 Mar; 61(3):165-71. PubMed ID: 15168797
[TBL] [Abstract][Full Text] [Related]
19. Protective efficacy of a sulfated sialyl lipid (NMSO3) against human rotavirus-induced diarrhea in a mouse model.
Takahashi K; Ohashi K; Abe Y; Mori S; Taniguchi K; Ebina T; Nakagomi O; Terada M; Shigeta S
Antimicrob Agents Chemother; 2002 Feb; 46(2):420-4. PubMed ID: 11796352
[TBL] [Abstract][Full Text] [Related]
20. Induction by human immunodeficiency viruses types 1 and 2 of degradation of CD4 but not of a CD4 mutant unable to bind viral envelope glycoproteins.
Cucchiarini M; Cagnon L; Giordanengo V; Doglio A; Lefebvre JC
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(5):427-36. PubMed ID: 7697438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
